Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perl

Showing results (141-150 of 3,149) with videos related to

Pageof 315
Sort By:
Antioxidants & Redox Signaling|March 7, 2001
Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV diseaseA Perl, K Banki
The Journal of Clinical Investigation|February 1, 1970
Long-term decay of serum cholesterol radioactivity: body cholesterol metabolism in normals and in patients with hyperlipoproteinemia and atherosclerosisP Samuel, W Perl
Methods in Molecular Medicine|August 3, 2004
Evaluation of autoimmunity to transaldolase in multiple sclerosisBrian Niland, Andras Perl
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|July 8, 2005
Dermatitis in a dairy herd caused by Pelodera strongyloides (Nematoda: Rhabditidae)I Yeruham, S Perl
International Journal of Clinical Rheumatology|March 9, 2010
Infection in systemic lupus erythematosus: friend or foe?Lisa Francis, Andras Perl
Reactive Oxygen Species (Apex, N.C.)|May 29, 2018
Measurement of Mitochondrial Mass by Flow Cytometry during Oxidative StressEdward Doherty, Andras Perl
FEBS Letters|January 8, 1996
Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesisK Banki, A Perl
International Journal of Cardiology|June 5, 2021
Reply to the letter by Wei et al. regarding the article, "Temporal trends of acute kidney injury in patients undergoing percutaneous coronary intervention over a span of 12 years"Keren Skalsky, Leor Perl
Immunometabolism (Cobham, Surrey)|October 31, 2022
Principles behind SLE treatment with <i>N</i>-acetylcysteineSandy Nasr, Andras Perl
Journal of Thoracic Disease|April 19, 2019
"No option" patients for coronary revascularization: the only thing that is constant is changeLeor Perl, Ran Kornowski
Pageof 315

Showing results (141-150 of 3,149) with videos related to

Sort By:
Pageof 315
Antioxidants & Redox Signaling|March 7, 2001
Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV diseaseA Perl, K Banki
The Journal of Clinical Investigation|February 1, 1970
Long-term decay of serum cholesterol radioactivity: body cholesterol metabolism in normals and in patients with hyperlipoproteinemia and atherosclerosisP Samuel, W Perl
Methods in Molecular Medicine|August 3, 2004
Evaluation of autoimmunity to transaldolase in multiple sclerosisBrian Niland, Andras Perl
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|July 8, 2005
Dermatitis in a dairy herd caused by Pelodera strongyloides (Nematoda: Rhabditidae)I Yeruham, S Perl
International Journal of Clinical Rheumatology|March 9, 2010
Infection in systemic lupus erythematosus: friend or foe?Lisa Francis, Andras Perl
Reactive Oxygen Species (Apex, N.C.)|May 29, 2018
Measurement of Mitochondrial Mass by Flow Cytometry during Oxidative StressEdward Doherty, Andras Perl
FEBS Letters|January 8, 1996
Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesisK Banki, A Perl
International Journal of Cardiology|June 5, 2021
Reply to the letter by Wei et al. regarding the article, "Temporal trends of acute kidney injury in patients undergoing percutaneous coronary intervention over a span of 12 years"Keren Skalsky, Leor Perl
Immunometabolism (Cobham, Surrey)|October 31, 2022
Principles behind SLE treatment with <i>N</i>-acetylcysteineSandy Nasr, Andras Perl
Journal of Thoracic Disease|April 19, 2019
"No option" patients for coronary revascularization: the only thing that is constant is changeLeor Perl, Ran Kornowski
Pageof 315